Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to ...

In a statement, the health minister said that all four patients (two male and two female) have mild form of infection and ...

The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

The national capital has reported 23 COVID-19 cases, prompting the Delhi government to issue an advisory asking all hospitals to prepare for the availability of beds, oxygen, medicines and vaccines.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.